CHILDRENS HEALTH CARE
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $3M
- Transactions
- 882
- Companies
- 40
- Average per transaction
- $3,368
Who reported the payments
| Jazz Pharmaceuticals Inc. | $756,107 |
| Vertex | $731,253 |
| Novo Nordisk AS | $279,485 |
| Merck | $239,647 |
| Soleno Therapeutics, Inc. | $171,663 |
| AstraZeneca | $111,504 |
| Biomarin Pharmaceutical Inc. | $79,242 |
| Regeneron | $61,328 |
| Sanofi | $54,918 |
| Gilead | $54,176 |
| Draeger Medical Systems, Inc | $47,520 |
| PTC Therapeutics, Inc. | $42,663 |
| Takeda Pharmaceuticals U.S.A., Inc. | $35,168 |
| Genentech, Inc. | $32,500 |
| Incyte Corporation | $30,797 |
| AbbVie | $26,773 |
| Bioverativ Therapeutics Inc. | $25,837 |
| Astellas Pharma Global Development | $24,552 |
| Astrazeneca UK Limited | $20,650 |
| Shire North American Group Inc | $19,061 |
| BD | $15,050 |
| Dova Pharmaceuticals | $14,697 |
| ONY Biotech Inc. | $12,550 |
| Optinose US, Inc. | $11,455 |
| Monteris Medical Corporation | $10,999 |
| Pfizer | $10,618 |
| Amgen | $10,440 |
| Abbott | $8,001 |
| Barco, Inc. | $6,000 |
| Medline Industries LP | $5,000 |
| Octapharma USA, Inc. | $5,000 |
| Daiichi Sankyo Inc. | $4,298 |
| Bard Peripheral Vascular, Inc. | $2,103 |
| Vero Biotech Inc. | $2,034 |
| Sanofi US Services Inc. | $1,602 |
| Grifols Therapeutics LLC | $1,500 |
| Cochlear Americas | $1,099 |
| KARL Storz Endoscopy-america | $1,000 |
| Swedish Orphan Biovitrum AB | $750 |
| Grifols Biologicals LLC | $750 |